Organic Letters
Letter
M. Adv. Synth. Catal. 2014, 356, 2375. (e) McGrath, N. A.; Brichacek,
M.; Njardarson, J. T. J. Chem. Educ. 2010, 87, 1348.
Further Grignard addition to this C4-substituted substrate was
highly stereoselective but gave a different stereochemical
outcome to that observed in the C4-unsubstituted example,
affording tetrasubstituted N-hydroxy-1,2,5,6-tetrahydropyridine
15. Subsequent reduction gave piperidine 16 with excellent
diastereoselectivity (99:1), as confirmed through 2D NOESY
NMR spectroscopy and crystal structure analysis (see the
(3) For reviews, see: (a) Bull, J. A.; Mousseau, J. J.; Pelletier, G.;
Charette, A. B. Chem. Rev. 2012, 112, 2642. (b) Buffat, M. G. P.
Tetrahedron 2004, 60, 1701. (c) Laschat, S.; Dickner, T. Synthesis
2000, 2000, 1781. (d) Stephens, D. E.; Larionov, O. V. Tetrahedron
2015, 71, 8683. (e) Cheng, G.; Weng, Y.; Yang, X.; Cui, X. Org. Lett.
2015, 17, 3790. (f) Goriya, Y.; Ramana, C. V. Chem. - Eur. J. 2012, 18,
13288.
In summary, we have demonstrated an efficient and
regiospecific alkyl Grignard addition to pyridine-N-oxides to
afford C2-alkylated N-hydroxy-1,2,5,6-tetrahydropyridines and
trans-2,3-disubstituted analogues in good to excellent yields.
These products were stereoselectively reduced to 2,3,4-tri- and
2,3,4,6-tetrasubstituted piperidine derivatives. We were also
able to use C-alkylation of pyridine-N-oxides to synthesize
valuable substituted pyridine derivatives from cheap and readily
available pyridine-N-oxide starting materials in a regiospecific
manner. Further investigations into the scope of this reaction
are currently underway in our laboratory.
(4) (a) Coia, N.; Mokhtari, N.; Vasse, J.-L.; Szymoniak, J. Org. Lett.
2011, 13, 6292. (b) Donohoe, T. J.; Basutto, J. A.; Bower, J. F.; Rathi,
A. Org. Lett. 2011, 13, 1036. (c) Guo, X.; Li, C.-J. Org. Lett. 2011, 13,
4977. (d) Guan, B.-T.; Hou, Z. J. Am. Chem. Soc. 2011, 133, 18086.
(5) (a) Genisson, Y.; Marazano, C.; Das, B. C. J. Org. Chem. 1993, 58,
2052. (b) Archibald, G.; Lin, C.-P.; Boyd, P.; Barker, D.; Caprio, V. J.
Org. Chem. 2012, 77, 7968. (c) Rioton, S.; Orliac, A.; Antoun, Z.;
Bidault, R.; Pardo, D. G.; Cossy, J. Org. Lett. 2015, 17, 2916.
(6) (a) Andersson, H.; Banchelin, T. S.-L.; Das, S.; Olsson, R.;
Almqvist, F. Chem. Commun. 2010, 46, 3384. (b) Andersson, H.;
Gustafsson, M.; Bostroem, D.; Olsson, R.; Almqvist, F. Angew. Chem.,
Int. Ed. 2009, 48, 3288. (c) Basu, B.; Das, S.; Das, P.; Mandal, B.;
Banerjee, D.; Almqvist, F. Synthesis 2009, 2009, 1137. (d) Andersson,
H.; Gustafsson, M.; Olsson, R.; Almqvist, F. Tetrahedron Lett. 2008,
49, 6901. (e) Andersson, H.; Almqvist, F.; Olsson, R. Org. Lett. 2007,
9, 1335. (g) Andersson, H.; Wang, X.; Bjoerklund, M.; Olsson, R.;
Almqvist, F. Tetrahedron Lett. 2007, 48, 6941. (h) Wang, X.; Kauppi,
A. M.; Olsson, R.; Almqvist, F. Eur. J. Org. Chem. 2003, 2003, 4586.
(i) Andersson, H.; Banchelin, T. S.-L.; Das, S.; Gustafsson, M.; Olsson,
R.; Almqvist, F. Org. Lett. 2010, 12, 284. (j) Andersson, H.; Olsson, R.;
Almqvist, F. Org. Biomol. Chem. 2011, 9, 337.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
Experimental procedures and spectroscopic and X-ray
crystallographic data for all new compounds (PDF)
(7) Hussain, M.; Banchelin, T. S.-L.; Andersson, H.; Olsson, R.;
Almqvist, F. Org. Lett. 2013, 15, 54.
(8) (a) Zhang, F.; Duan, X. F. Org. Lett. 2011, 13, 6102. (b) Zhang,
S.; Liao, L. Y.; Zhang, F.; Duan, X. F. J. Org. Chem. 2013, 78, 2720.
(c) Zhuo, A. F.; Xie, W. W.; Yang, Y. X.; Zhang, L.; Wang, P.; Yuan,
R.; Da, C. S. J. Org. Chem. 2013, 78, 3243. (d) Larionov, O. V.;
Stephens, D.; Mfuh, A.; Chavez, G. Org. Lett. 2014, 16, 864. (e) Shen,
Y.; Chen, J.; Liu, M.; Ding, J.; Gao, W.; Huang, X.; Wu, H. Chem.
Commun. 2014, 50, 4292. (f) Zhang, F.; Zhang, S.; Duan, X. F. Org.
Lett. 2012, 14, 5618.
(9) (a) Lee, S. T.; Green, B. T.; Welch, K. D.; Pfister, J. A.; Panter, K.
E. Chem. Res. Toxicol. 2008, 21, 2061. (b) Beng, T. K.; Gawley, R. E. J.
Am. Chem. Soc. 2010, 132, 12216.
(10) (a) Bilke, J. L.; Moore, S. P.; O’Brien, P.; Gilday, J. Org. Lett.
2009, 11, 1935. (b) Arena, G.; Zill, N.; Salvadori, J.; Girard, N.; Mann,
A.; Taddei, M. Org. Lett. 2011, 13, 2294.
(11) For the haptophilic contribution of hydroxyl groups, see:
(a) Gualandi, A.; Savoia, D. RSC Adv. 2016, 6, 18419. (b) Thompson,
H. W.; McPherson, E.; Lences, B. L. J. Org. Chem. 1976, 41, 2903.
(12) For the synthesis of polysubstituted piperidines, see:
(a) Takahashi, M.; Micalizio, G. C. J. Am. Chem. Soc. 2007, 129,
7514. (b) Wang, Y.; Yu, D.-F.; Liu, Y. Z.; Wei, H.; Luo, Y.-C.; Dixon,
D. J.; Xu, P.-F. Chem. - Eur. J. 2010, 16, 3922. (c) Urushima, T.;
Sakamoto, D.; Ishikawa, H.; Hayashi, Y. Org. Lett. 2010, 12, 4588.
(d) Sun, Z.; Yu, S.; Ding, Z.; Ma, D. J. Am. Chem. Soc. 2007, 129, 9300.
(e) Sales, M.; Charette, A. B. Org. Lett. 2005, 7, 5773.
AUTHOR INFORMATION
■
Corresponding Authors
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the Swedish Research Council (F.A., M.T.J., and
R.O.), the Knut and Alice Wallenberg Foundation (F.A.), the
Goran Gustafsson Foundation (F.A.), and the Swedish
Foundation for Strategic Research (F.A.) for financial support.
D.K.B. thanks the Kempe Foundation for Scientific Research
for providing a postdoctoral fellowship. We also thank Mattias
̈
Hedenstorm (Umea University) for the NMR study. This study
̊
made use of the “NMR for Life” infrastructure, which is
supported by the Knut and Alice Wallenberg Foundation, the
University of Gothenburg, and Umea University.
̊
(13) Crystallographic data for 2p, 7p, 11, 13, and 16 have been
deposited with the Cambridge Crystallographic Data Centre as CCDC
numbers 1479099, 1479111, 1479100, 479102, and 1487575,
respectively. These data can be obtained free of charge from the
REFERENCES
■
(1) (a) Jones, T. H.; Blum, M. S.; Robertson, H. G. J. Nat. Prod.
1990, 53, 429. (b) Nara, S.; Tanaka, R.; Eishima, J.; Hara, M.;
Takahashi, Y.; Otaki, S.; Foglesong, R. J.; Hughes, P. F.; Turkington,
S.; Kanda, Y. J. Med. Chem. 2003, 46, 2467. (c) He, R.; Kurome, T.;
Giberson, K. M.; Johnson, K. M.; Kozikowski, A. P. J. Med. Chem.
2005, 48, 7970.
(2) (a) Li, M.; Li, X.; Chang, H.; Gao, W.; Wei, W. Org. Biomol.
Chem. 2016, 14, 2421. (b) Campeau, L. C.; Rousseaux, S.; Fagnou, K.
J. Am. Chem. Soc. 2005, 127, 18020. (c) Leclerc, J.-P.; Fagnou, K.
Angew. Chem., Int. Ed. 2006, 45, 7781. (d) Yan, G.; Borah, A. J.; Yang,
D
Org. Lett. XXXX, XXX, XXX−XXX